iShares 0 3 Month Treasury Bond ETF vs 22nd Century Group Inc — how do they compare? iShares 0 3 Month Treasury Bond ETF trades at $100.52 (market cap $114.40B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: iShares 0 3 Month Treasury Bond ETF is far larger — about 184020.5× 22nd Century Group Inc's market cap, and iShares 0 3 Month Treasury Bond ETF is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares 0 3 Month Treasury Bond ETF for 50 Days and 22nd Century Group Inc for 32 Days on average.
| SGOV | XXII | |
|---|---|---|
Market Cap | $114.40B | $621.67K |
Volume | 18,879,081 | 45,625 |
Sector | Fixed Income | Consumer Staples |
52-Week High | $100.72 | $483.00 |
52-Week Low | $100.28 | $0.80 |
Typical Hold Time | 50 Days | 32 Days |
Enterprise Value | — | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
SGOV (iShares 0-3 Month Treasury Bond ETF) trades at $100.47 with minimal daily price movement, reflecting its ultra-short-term Treasury bond focus. The technical picture shows bearish momentum with moving averages signaling caution, while oscillators remain neutral. Recent corporate actions include consistent dividend distributions around $0.30-0.31 per share through mid-2026.
As a Treasury bond ETF, SGOV offers low volatility and regular income but faces headwinds from rising interest rates. The fund provides exposure to short-term government debt with minimal credit risk, though higher yields elsewhere may pressure returns. Current bond market volatility creates both challenges and opportunities for short-term fixed income investors.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.
Read more on SGOV →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →